Endodontic treatment has traditionally been conceptualized as a procedure focused on eliminating intracanal microorganisms and sealing the root canal system. While this approach has driven significant technical innovation, it does not fully account for the variability observed in treatment outcomes. Ever-increasing biological evidence suggests that the host response plays a decisive role in determining whether endodontic therapy results in healing or failure. Microorganisms initiate apical disease; however, it is the host’s immune and inflammatory response that ultimately leads to tissue destruction, symptom expression, and repair.1 Apical periodontitis is best understood as an immunoinflammatory disease rather than a simple infection. Microbial by-products exiting the root canal activate immune mechanisms, leading to recruitment of inflammatory cells. These cells release cytokines and osteolytic mediators that drive periapical bone resorption.2 Importantly, reduction of the microbial stimulus through endodontic treatment does not immediately terminate this inflammatory cascade. Host-derived mediators may persist beyond canal disinfection, influencing the pace and predictability of healing.1,3 A critical but most-often overlooked aspect of the host response is its heterogeneity. Patients exposed to similar microbial challenges and treated using comparable techniques frequently demonstrate markedly different healing outcomes. This variability may reflect the underlying differences in immune regulation, cytokine expression profiles, and resolution pathways. This biological diversity challenges the assumption that endodontic success is purely technique-driven and highlights the role of host susceptibility in treatment failure.3 Patients with particular types of single-nucleotide polymorphisms are associated with increased risk of developing pain after root canal treatment.4 Systemic health further modulates the host response and influences treatment outcome. Diabetes mellitus, in particular, has been consistently associated with impaired immune function, altered bone metabolism, and delayed healing. Even when microbial control is achieved, these systemic alterations may predispose patients to persistent inflammation or incomplete resolution of apical lesions.5 Host-derived enzymes represent another key biological factor affecting outcomes. Matrix metalloproteinases, released from inflammatory cells and resident tissues, play an essential role in extracellular matrix degradation and bone resorption. While these enzymes are necessary for normal tissue remodeling, excessive or prolonged activation may perpetuate inflammation and delay healing, even after technically adequate treatment.6 Such host-mediated tissue breakdown may clinically resemble persistent disease. Clinically, an appreciation of host response reshapes how endodontic success and failure are interpreted. Persistent radiolucency’s or posttreatment symptoms should not automatically be equated with microbial persistence. Instead, they may reflect an exaggerated or poorly regulated inflammatory response. Recognizing this distinction encourages more biologically informed decision-making and discourages overtreatment. In conclusion, the outcome of endodontic treatment is not dictated solely by microbial elimination or procedural precision. It is the result of a dynamic interaction between microbial challenge and host response. Viewing endodontic disease through this lens will change our philosophy and approach toward endodontic treatment, from being purely technique driven to a biologically-lead harmonious equilibrium between the host and intervention.
Singh et al. (Sun,) studied this question.